ATE172988T1 - Die mac-1-bindungsstelle von icam-1 - Google Patents
Die mac-1-bindungsstelle von icam-1Info
- Publication number
- ATE172988T1 ATE172988T1 AT91119894T AT91119894T ATE172988T1 AT E172988 T1 ATE172988 T1 AT E172988T1 AT 91119894 T AT91119894 T AT 91119894T AT 91119894 T AT91119894 T AT 91119894T AT E172988 T1 ATE172988 T1 AT E172988T1
- Authority
- AT
- Austria
- Prior art keywords
- icam
- mac
- binding site
- relates
- molecules
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ropes Or Cables (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Hall/Mr Elements (AREA)
- Package Frames And Binding Bands (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/618,286 US5288854A (en) | 1990-11-28 | 1990-11-28 | Functional derivatives of ICAM-1 which are substantially capable of binding to LFA-1 but are substantially incapable of binding to MAC-1 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE172988T1 true ATE172988T1 (de) | 1998-11-15 |
Family
ID=24477094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT91119894T ATE172988T1 (de) | 1990-11-28 | 1991-11-21 | Die mac-1-bindungsstelle von icam-1 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5288854A (de) |
| EP (1) | EP0488061B1 (de) |
| KR (1) | KR920009412A (de) |
| AT (1) | ATE172988T1 (de) |
| DE (1) | DE69130445T2 (de) |
| DK (1) | DK0488061T3 (de) |
| ES (1) | ES2122964T3 (de) |
| NZ (2) | NZ260473A (de) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284931A (en) * | 1987-05-04 | 1994-02-08 | Dana Farber Cancer Institute | Intercellular adhesion molecules, and their binding ligands |
| US6051231A (en) * | 1988-09-01 | 2000-04-18 | Bayer Corporation | Antiviral methods and prepations |
| US6143298A (en) * | 1988-09-01 | 2000-11-07 | Bayer Corporation | Soluble truncated forms of ICAM-1 |
| EP0362531B1 (de) | 1988-09-01 | 1999-11-10 | Bayer Corporation | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
| US6514936B1 (en) | 1988-09-01 | 2003-02-04 | Bayer Corporation | Antiviral methods using human rhinovirus receptor (ICAM-1) |
| US6797270B1 (en) | 1989-03-16 | 2004-09-28 | Center For Blood Research, Inc. | Functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
| US6107461A (en) * | 1990-07-20 | 2000-08-22 | Bayer Corporation | Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
| ATE184049T1 (de) * | 1990-07-20 | 1999-09-15 | Bayer Ag | Multimere formen des menschlichen rhinovirus- rezeptorproteins |
| US6130202A (en) * | 1990-07-20 | 2000-10-10 | Bayer Corporation | Antiviral methods |
| GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
| US5811517A (en) * | 1992-01-27 | 1998-09-22 | Icos Corporation | ICAM-related protein variants |
| WO1994008620A1 (en) * | 1992-10-09 | 1994-04-28 | Center For Blood Research, Inc. | A subpopulation of mac-1 (cd11b/cd18) molecules which mediate neutrophil adhesion to icam-1 and fibrinogen |
| US6001356A (en) * | 1995-09-29 | 1999-12-14 | Rush-Presbyterian-St. Luke's Medical Center | Method of inhibiting tissue destruction in autoimmune disease using anti-CD44 antibodies |
| JP4451933B2 (ja) * | 1996-12-27 | 2010-04-14 | 住友化学株式会社 | 遺伝子操作による植物へのppo阻害性除草剤耐性付与法 |
| ATE298248T1 (de) * | 1998-04-15 | 2005-07-15 | Brigham & Womens Hospital | T-zell inhibierende rezeptorzusammensetzungen sowie deren verwendung |
| US6331640B1 (en) | 1998-10-13 | 2001-12-18 | Hoffmann-La Roche Inc. | Diaminopropionic acid derivatives |
| US6867203B2 (en) | 1998-12-29 | 2005-03-15 | Abbott Laboratories | Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| CA2417432C (en) * | 2000-09-01 | 2010-11-02 | The Center For Blood Research, Inc. | Modified polypeptides stabilized in a desired conformation and methods for producing same |
| IL155683A0 (en) * | 2000-11-28 | 2003-11-23 | Genentech Inc | Lfa-1 antagonist compounds |
| AU2004287875B2 (en) | 2003-11-05 | 2011-06-02 | Bausch + Lomb Ireland Limited | Modulators of cellular adhesion |
| WO2006023491A2 (en) | 2004-08-16 | 2006-03-02 | The Cbr Institute For Biomedical Research, Inc. | Method of delivering rna interference and uses thereof |
| US20060233675A1 (en) * | 2005-04-13 | 2006-10-19 | Stein Israel M | Glass test tube having protective outer shield |
| SI1881823T1 (sl) * | 2005-05-17 | 2015-04-30 | Sarcode Bioscience Inc. | Sestavki in postopki za zdravljenje bolezni oäśesa |
| WO2007127272A2 (en) * | 2006-04-24 | 2007-11-08 | The Cbr Institute For Biomedical Research | Method of producing immunoliposomes and compositions thereof |
| US20130129752A1 (en) * | 2006-04-25 | 2013-05-23 | Immune Disease Institute, Inc. | Targeted delivery to leukocytes using protein carriers |
| CA2702984C (en) | 2007-10-19 | 2017-04-11 | Sarcode Corporation | Compositions and methods for treatment of diabetic retinopathy |
| EP2276508A4 (de) * | 2008-04-15 | 2011-12-28 | Sarcode Bioscience Inc | Freisetzung von lfa-1-antagonisten gegen das magen-darm-system |
| EP3632444A3 (de) * | 2008-04-15 | 2020-08-26 | SARcode Bioscience Inc. | Topische lfa-1-antagonisten zur verwendung in der lokalen behandlung von immunerkrankungen |
| WO2009139817A2 (en) * | 2008-04-15 | 2009-11-19 | Sarcode Corporation | Crystalline pharmaceutical and methods of preparation and use thereof |
| CN102065694A (zh) * | 2008-04-15 | 2011-05-18 | 萨可德公司 | 用于局部治疗免疫相关疾病的雾化的lfa-1拮抗剂 |
| US8378105B2 (en) * | 2009-10-21 | 2013-02-19 | Sarcode Bioscience Inc. | Crystalline pharmaceutical and methods of preparation and use thereof |
| EP2877465A4 (de) | 2012-07-25 | 2016-05-11 | Sarcode Bioscience Inc | Lfa-1-hemmer und polymorph davon |
| US20170173005A1 (en) | 2014-03-27 | 2017-06-22 | Research Foundation Of The City University Of New York | Method for detecting or treating triple negative breast cancer |
| JP7728701B2 (ja) | 2018-12-17 | 2025-08-25 | レビトープ リミテッド | 双子型免疫細胞エンゲージャー |
| US12362079B2 (en) | 2020-12-18 | 2025-07-15 | École De Technologie Supérieure | Method for manufacturing an electrically conductive composite |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE114972T1 (de) * | 1987-11-02 | 1994-12-15 | Baylor College Medicine | Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen. |
| EP0362531B1 (de) * | 1988-09-01 | 1999-11-10 | Bayer Corporation | Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt |
| ES2077572T3 (es) * | 1988-09-28 | 1995-12-01 | Dana Farber Cancer Inst Inc | Moleculas de adhesion intercelular, y sus ligandos de fijacion. |
-
1990
- 1990-11-28 US US07/618,286 patent/US5288854A/en not_active Expired - Lifetime
-
1991
- 1991-11-21 ES ES91119894T patent/ES2122964T3/es not_active Expired - Lifetime
- 1991-11-21 AT AT91119894T patent/ATE172988T1/de active
- 1991-11-21 DK DK91119894T patent/DK0488061T3/da active
- 1991-11-21 DE DE69130445T patent/DE69130445T2/de not_active Expired - Fee Related
- 1991-11-21 EP EP91119894A patent/EP0488061B1/de not_active Expired - Lifetime
- 1991-11-26 KR KR1019910021347A patent/KR920009412A/ko not_active Abandoned
- 1991-11-26 NZ NZ260473A patent/NZ260473A/en unknown
- 1991-11-26 NZ NZ240747A patent/NZ240747A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2122964T3 (es) | 1999-01-01 |
| US5288854A (en) | 1994-02-22 |
| EP0488061B1 (de) | 1998-11-04 |
| NZ260473A (en) | 1997-06-24 |
| NZ240747A (en) | 1996-05-28 |
| DE69130445T2 (de) | 1999-07-08 |
| DK0488061T3 (da) | 1999-07-19 |
| DE69130445D1 (de) | 1998-12-10 |
| EP0488061A3 (en) | 1992-08-26 |
| EP0488061A2 (de) | 1992-06-03 |
| KR920009412A (ko) | 1992-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69130445D1 (de) | Die Mac-1-Bindungsstelle von ICAM-1 | |
| EP0730609A4 (de) | In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper | |
| DK0445255T4 (da) | Anvendelse af hyaluronsyre i kombination med ascorbinsyre, antitumormidler og/eller NSAID's til behandling af cancer | |
| GR3006073T3 (de) | ||
| DE58902094D1 (de) | Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen. | |
| ATE126441T1 (de) | Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen. | |
| ATE32730T1 (de) | Indikatormarkierte konjugate von metallothionein und zielsuchenden, biologisch aktiven molekuelen. | |
| DE69333321D1 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
| FI883936A7 (fi) | Sokeritaudin hoito, hoidossa käyttökelpoiset valmisteet ja niiden valmistus | |
| DK0745852T3 (da) | Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi | |
| ATE238047T1 (de) | Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz | |
| DE3880212D1 (de) | Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten. | |
| ATE99932T1 (de) | Verwendung von pyrrolicloncarbonsaeurealkylestern zur herstellung eines arzneimittels zur behandlung von ichtyosis. | |
| IT8419681A0 (it) | Composizioni farmaceutiche per il trattamento del diabete e di malattie e disfunzioni epatiche. | |
| IT1254521B (it) | Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare | |
| FI924475A7 (fi) | Trinitrobentseenien tai karmiinihapon käyttö syövän ja virusperäisten sairauksien hoidossa | |
| FI954138A7 (fi) | Hydroksimetyylifuratsaanikarboksyylihappojohdannaiset ja niiden käyttö sydänverisuonitautien käsittelyssä | |
| DE59002772D1 (de) | Verwendung von Dextransulfat, gegebenenfalls in Kombination mit anti-androgenen Mitteln zur Behandlung des humanen Protatakarzinoms. | |
| EP0757697A4 (de) | Verwendung von agentien, die die interzellülare wechselwirkung inhibieren, in der behandlung von viralen infektionen des atemweges | |
| DE3863200D1 (de) | In der krebstherapie verwendbare zusammensetzung auf der basis von aminosaeure und vitaminen. | |
| DK468885A (da) | Middel til topisk behandling af betaendelsestilstande i huden | |
| IT1221010B (it) | Impiego di chinoloni nel trattamento di malattie cardiache | |
| OA08355A (fr) | Nouveaux benzamides, leur procédé de préparation et leur application dans le domaine thérapeutique. | |
| ATE74755T1 (de) | Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit. | |
| ATE79759T1 (de) | Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen. |